Robert J. Soiffer, MD, is Chief of the Division of Hematologic Malignancies and Chair of the Executive Committee for Clinical Programs at Dana Farber Cancer Institute as well as the Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology at Harvard Medical School.

Dr. Soiffer served as President of the American Society for Transplant and Cellular Therapies and Chair of the Advisory Board for the Center for International Blood and Marrow Transplant Research. He is a member of the Executive Steering Committees for Blood and Marrow Transplant Clinical Trials Network. Dr. Soiffer is Immediate Past Chair of the Board of Directors for the National Marrow Donor Program.

Dr. Soiffer conducts research focused on modulation of immune reconstitution in the setting of allogeneic hematopoietic stem cell transplantation (allo-HCT). His goal is to develop technologies to improve patient outcomes by optimizing graft versus leukemia (GVL) activity without inducing graft versus host disease (GVHD). Dr. Soiffer has co-authored more than 400 peer-reviewed manuscripts and numerous book chapters, review articles, editorials, and monographs.